May 4, 2018 / 5:01 PM / 2 months ago

BRIEF-FDA Approves New Uses For 2 Drugs Administered Together For Braf-Positive Anaplastic Thyroid Cancer

May 4 (Reuters) - U.S. Food and Drug Administration:

* FDA APPROVES NEW USES FOR TWO DRUGS ADMINISTERED TOGETHER FOR THE TREATMENT OF BRAF-POSITIVE ANAPLASTIC THYROID CANCER

* FDA - APPROVES NEW USES FOR TWO DRUGS ADMINISTERED TOGETHER FOR TREATMENT OF BRAF-POSITIVE ANAPLASTIC THYROID CANCER

* FDA - APPROVED TAFINLAR, MEKINIST FOR TREATMENT OF ANAPLASTIC THYROID CANCER THAT CANNOT BE REMOVED BY SURGERY OR HAS SPREAD TO OTHER PARTS OF BODY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below